The Research Question 1) What is the contemporary prevalence of Active Surveillance (AS) adoption among men newly diagnosed with low-risk localized prostate.

Slides:

Advertisements

Similar presentations

Cap.org v. # Pathologists’ Role in Coordinated Care and Managing Patient Populations.

Advertisements

Epidemiology of prostate cancer Epidemiology and Molecular Pathology of Cancer: Bootcamp course Tuesday, 3 January 2012.

NCHS Data – Strengths and Weaknesses from the NHLBI Perspective Paul Sorlie, Ph.D. Chief, Epidemiology Branch National Heart, Lung, and Blood Institute.

Genetic Causation for Mortality Disparity among Young African-American Men.

Quality Cancer Data The Vital Role of Cancer Registrars in the Fight against Cancer Saves Lives.

M Ravanbod Medical oncologist Bushehr – 11/91 A 50 y/o white man comes for check up and wants to discuss about prostate cancer. Negative family history.

Labor Market Outcomes of Cancer Survivors NCI R01 CA A1.

HSS4303B – Intro to Epidemiology

Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.

Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.

Quality of Life and Depression as Determinants of Treatment Adherence in Hypertensive Leonelo E. Bautista 1 ; Paul Smith 2 ; Cynthia Colombo 2 ; Dennis.

Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.

INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.

National Program of Cancer Registries

Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.

“The African American Prostate Cancer Crisis in Numbers”

Prostate Cancer Screening in African American Men Mark H. Kawachi, MD FACS Director, Prostate Cancer Center City of Hope, National Medical Ctr.

PCa Screening New Areas of Research Francesco Montorsi Milan.

RTI Health Solutions Practical and Methodological Issues in Long-Term Follow-Up Studies Elizabeth B. Andrews, Ph.D. Vice President, RTI Health Solutions.

SEER Provided Data Mohammad Afnan Baqai 12/3/2009.

SMOKING AND ESTABLISHED CARDIOVASCULAR DISEASE: THE VARIABLE HABITS OF A PRIMARY CARE COHORT Dr Mairead Corrigan 1 PhD BSSc, Dr Margaret E Cupples 1 MD.

Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.

Case Control Study Dr. Ashry Gad Mohamed MB, ChB, MPH, Dr.P.H. Prof. Of Epidemiology.

Causal relationships, bias, and research designs Professor Anthony DiGirolamo.

The case for HIV testing A presentation for the clinical team in your practice.

The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.

SEER Data Cancer Project Brett Langsjoen. SEER Surveillance, Epidemiology, and End Results Program of the National Cancer Institute (NCI) Purpose: Collect.

Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,

HIV and STI Department The case for HIV testing A presentation for the clinical team in your practice.

Co-infections of Hepatitis C or Tuberculosis Among Persons Living with HIV in The Florida Cohort Project Alexander Zirulnik MPH, Chukwuemeka Okafor MPH,

Using SEER-Medicare Data to Enhance Registry Data to Assess Quality of Care Joan Warren Applied Research Program National Cancer Institute NAACCR June.

South West Public Health Observatory The changing casemix of prostate cancer patients and prostatectomies in the South West Sean McPhail.

Postsurgical Risk Factors for Prostate Cancer Mortality Slideset on: Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer–specific mortality.

CHEST 2014; 145(4): 호흡기내과 R3 박세정. Cigarette smoking ㅡ the most important risk factor for COPD in the US. low value of FEV 1 : an independent predictor.

Case Control study. An investigation that compares a group of people with a disease to a group of people without the disease. Used to identify and assess.

What does the data tell us? Colorectal CANCER IN NEVADA

BREAST CANCER IN SETTING OF HIGH HIV PREVALENCE

Radiation therapy for Early Stage Prostate Cancer

Cancer Statistics 2016 A Presentation from the American Cancer Society

Cancer Statistics 2016 A Presentation from the American Cancer Society

Population-Based Cancer Registries in the United States:

Surveillance Research Program

Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms? Mark J. Speakman European Urology Supplements

PHEN Clinical Trials Rally

Amanda D. Castel, MD, MPH Assistant Research Professor

(2) - Department of Epidemiology and Population Health, and

Believed discrimination occurred because of their:

Prostate cancer isn’t colorblind

PHQ2 Screening Negative PHQ2 Screening Positive

It is estimated that about 1

It is estimated that almost 1

Bronx Community Health Dashboard: Prostate Cancer Last Updated: 1/19/2018 See last slide for more information about this project.

Stephen Ansell, MD, PhD Mayo Clinic

Figure 3 Semantic model of the active surveillance (AS) timeline

Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms? Mark J. Speakman European Urology Supplements

Dramatic Declines in Lifetime HIV Risk and Persistence of Racial Disparities among Men Who Have Sex with Men in King County, Washington, USA IAS 2015.

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Mirela Anghelina, M.D., M.P.H.

Physical Activity and Endometrial Cancer Survival

It is estimated that more than 1

National Cancer Statistics in Korea, 2015

Needs Assessment Slides for Module 4

Physical Activity and Endometrial Cancer Survival

Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms? Mark J. Speakman European Urology Supplements

NAACCR/IACR Combined Annual Conference 2019

Types of questions TVEM can answer

NAACCR/IACR Annual Conference, June 2019

Presentation transcript:

The Research Question 1) What is the contemporary prevalence of Active Surveillance (AS) adoption among men newly diagnosed with low-risk localized prostate cancer (LPC)? 2) Are there any racial and/or geographical differences in AS adoption, adherence to AS protocol and switch rates and time to curative treatment over 18 months follow-up? 3) What are the differences in quality-of-life (QOL) measures between the AS group and curative treatment group over the course of 18 months, overall and by race?

Research Design and Method Design: Longitudinal cohort study Setting: Population-based sample recruited from 2 SEER Cancer Registries (Metro-Detroit & State of Georgia) Participants: Black and white men ≤75 years, newly diagnosed (2014-2017) low-risk LPC (PSA<10, Gleason≤6, & stage ≤T2a) Instrument: Self-administered, mailed survey at: Baseline (soon after diagnosis) 18 months follow-up (after baseline) Main Outcome Measure: Treatment choice Quality of life

What the Research Found In this population-based sample (~1700), ~55% of patients with low-risk LPC chose observation initially, most chose AS This represents much higher rate of uptake of AS comparing to 10-15% 5 to 10 years ago, even higher than other recent reports from non-population-based cohort 35-45% Treatment choice was associated with race and geographical location Black men chose AS less often than white men (p=0.001) Black men choose radiation more often than white men with this difference being larger in Georgia (p=0.016) Data collection is ongoing for the 18 month-follow-up of QOL and AS adherence and switch rates and reasons for the switch

What this means for Clinical Practice Our population-based cohort confirmed the recent reports of upward trend of AS adoption among men with newly diagnosed low-risk LPC This suggests both men and their physicians are more accepting of AS than previously reported The reasons for the racial and geographical differences in treatment pattern of low-risk LPC deserve more research so that unwanted treatment patterns could be minimized Comparison data on QOL between AS group and curative treatment group over 18 month-follow-up to be analyzed/announced